Zimmer Biomet Holdings Stock Price and Value Analysis

Should you buy Zimmer Biomet Holdings stock? (NYSE:ZBH). Let's see how it does in our automated value investing analysis system.

ZBH Free Cash Flow Trend

Free Cash Flow trendline for ZBH
Free Cash Flow trendline for Zimmer Biomet Holdings

Hmm, we can't give any reliable projection for Zimmer Biomet Holdings's growth rate. The company either has too few years of historical data for us to examine, or it's in the habit of losing money.

None of this means it's a bad stock. Maybe it's new and growing quickly, or maybe it's turning things around. We can't say anything sensible about it, so we won't say it's obviously undervalued right now. Proceed at your own risk!

AdvantagesDisadvantages
None.
  • This stock looks overpriced.
  • This company has a low dividend yield.
  • This company has wild ups and downs.
  • This company is less known than others.
  • This company is not making money.

Inside the ZBH Numbers

ZBH Price
(Zimmer Biomet Holdings stock price per share)
$114.52
[?] PE Ratio versus Sector 36% lower than other Healthcare stocks
[?] PE Ratio versus Industry 0% lower than other Medical Devices stocks
[?] Free Cash Flow Jitter 59%
[?] Dividend Yield 1%

Is Zimmer Biomet Holdings Stock on Sale?

Based on our analysis, we believe that you should not buy Zimmer Biomet Holdings right now. It might be a good stock to own—we just can't prove it with value analysis right now. Proceed with caution.

Should You Buy ZBH Stock?

Does Zimmer Biomet Holdings have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.